The 2026 Hemp Ban: What Changes, Who's Affected, and What to Do About It

On November 12, 2026, the way federal law defines "hemp" changes, and with it the legal status of roughly 95% of the intoxicating hemp products currently sold in the United States.

This is the single most consequential piece of cannabis regulation since the 2018 Farm Bill legalized hemp in the first place. For consumers who've been buying delta-8 gummies at smoke shops, ordering hemp-derived THC beverages online, or picking up THCA flower at gas stations, the product category goes away at the federal level. For operators running state-licensed cannabis businesses, the ban changes nothing about their legal standing and probably shifts a significant slice of displaced consumer demand toward the dispensary channel. For the hemp industry itself, it's an extinction-level event estimated by the U.S. Hemp Roundtable to eliminate up to 95% of current SKUs.

This page is a living document. We update it whenever the legal situation moves. What follows is a comprehensive breakdown of what the law actually does, what's in active litigation, what it means state by state, what to do if you're a consumer or an operator, and answers to the questions people are actually searching.

What does Section 781 of H.R. 5371 actually change?

Section 781 of H.R. 5371 amends the Agricultural Marketing Act's definition of hemp in three ways. It replaces the delta-9-only test with a total-THC standard, caps finished-product THC at 0.4mg per container, and excludes synthetic and lab-converted cannabinoids from the hemp definition. The combined effect removes roughly 95% of intoxicating hemp products from federal legality starting November 12, 2026.

Congress passed H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 on November 12, 2025, and President Trump signed it the same day. Section 781 of Division B is where the hemp redefinition lives, and the three changes below are what carry the federal effect.

Change one: total THC replaces delta-9-only. The old definition (from the 2018 Farm Bill) classified cannabis as hemp if it contained less than 0.3% delta-9 THC by dry weight. Everything else (delta-8, delta-10, THCA, HHC, THCP) sat outside the definition, unregulated by concentration. This is the loophole the entire intoxicating hemp industry was built on. The new definition counts all psychoactive cannabinoids toward the 0.3% ceiling. A plant that was legal hemp on November 11, 2026 because its delta-9 content was 0.2% and its THCA content was unmeasured becomes non-hemp on November 12, 2026 because the THCA converts to THC when heated and the total THC reading exceeds 0.3%.

Change two: a 0.4 milligram per container cap for finished products. This is the rule that guts the consumable market. Any final hemp-derived product with more than 0.4mg of total THC per container is excluded from the definition of hemp and pushed back into Schedule I under the Controlled Substances Act. For reference, a standard dispensary gummy contains 5-10mg per piece, and a typical hemp-derived gummy on the market today contains 25-50mg per piece. The 0.4mg container cap covers the entire package, not per serving. A 20-count jar has 0.4mg total to distribute. That's roughly 1/12th of a single standard dose spread across 20 gummies.

Change three: synthetic and lab-converted cannabinoids are excluded. Products containing cannabinoids that are not capable of being naturally produced by Cannabis sativa L., or that are capable of being naturally produced but were synthesized or manufactured outside the plant, are explicitly carved out of the hemp definition. Delta-8 THC is almost entirely produced through acid-catalyzed isomerization of CBD. Under the new definition, that conversion process disqualifies the product regardless of concentration. HHC, THCP, and other lab-derived cannabinoids face the same exclusion.

The effective date is November 12, 2026. The FDA is required to publish lists of naturally occurring cannabinoids, THC-class cannabinoids, and all known cannabinoids with similar effects within 90 days of enactment. FDA was also directed to further define "container" for purposes of the 0.4mg cap.

What hemp products stay legal after November 12, 2026?

Industrial hemp for fiber, seed, and construction stays legal. So do CBD products under the 0.4mg total THC per container threshold, hemp seed as a food ingredient, and trace-THC topicals below the cap. State-licensed cannabis is unaffected since Section 781 amends the Agricultural Marketing Act. State cannabis programs are not in scope.

The U.S. Hemp Roundtable estimates that over 90% of currently marketed CBD products exceed the new 0.4mg per container threshold, even many that are marketed as non-intoxicating. Most CBD brands will need to reformulate to lower-THC isolate or full-spectrum-within-limits products to continue selling after November 12. Brands like Charlotte's Web, Cornbread Hemp, and the isolate lines from larger operators are positioned to survive because their product mix leans heavily toward isolate.

On the state-licensed side, a California, Michigan, Illinois, Massachusetts, New York, Colorado, or Nevada dispensary selling 10mg THC gummies in April 2026 is selling them through the same state-licensed channel on November 13, 2026. State programs operate under state law against a federal Schedule I backdrop that existed before November 12 and does not change after it. The only variables that shift are demand and price, both of which are discussed below.

The active litigation: why enforcement is already uneven

The federal law is set. The implementation is not. As of this update (August 24, 2026), Texas enforcement is back on after an appeals court lifted the injunction, Ohio's ban stands with narrow court-ordered carve-outs for specific plaintiffs, and the federal deadline has not moved.

Texas. The Texas Department of State Health Services (DSHS) Consumable Hemp Program issued rules on March 31, 2026, imposing a total-THC standard at the state level, effectively banning THCA flower, smokable hemp, and most consumable hemp products, and raising retailer fees from $150 to $5,000 per location. The Texas Hemp Business Council and industry co-plaintiffs sued in Travis County on April 7, won a TRO on April 8, and on May 1 won a statewide temporary injunction from Judge Daniella DeSeta Lyttle covering the total-THC standard, the fee increases, and per-day penalty stacking. The state appealed, and on June 8 the Fifteenth Court of Appeals lifted the injunction. The rules are back in effect, and DSHS has said publicly that it is still deciding how to enforce them while the case remains unresolved, which leaves Texas retailers selling under rules the state has not committed to acting on. The industry filed a motion on June 23 asking the appeals court to reinstate the injunction. The merits trial set for July 27 was vacated as the case moved up on appeal, leaving the rule's timeline unresolved.

The separate Sky Marketing case (the Hometown Hero case) resolved against the hemp industry. On May 1, the same day the Travis County injunction came down, the Texas Supreme Court ruled that DSHS has broad authority to schedule substances and let a 2021 delta-8 classification stand where the Legislature has not expressly overruled it. The ruling cuts against the industry's core argument in the current case, that only the Legislature can rewrite the definition of hemp, and it makes the industry's path on appeal a harder climb.

Ohio. The state passed Senate Bill 56 in December 2025, enacting a state-level ban on intoxicating hemp products that took effect in March 2026. Two separate Ohio courts have since issued injunctions blocking enforcement for specific plaintiffs. On April 8, 2026, a Sandusky County judge blocked enforcement against hemp retailers in Fremont. On April 16, a Franklin County judge issued a TRO against enforcement for two Columbus-area plaintiffs, with a preliminary injunction hearing expected within two weeks.

The referendum campaign against SB 56 is dead. Ohioans for Cannabis Choice failed to submit the roughly 250,000 valid signatures needed by the March deadline, so the law stands and the question will not appear on the November ballot. On July 13, a federal judge granted a preliminary injunction blocking SB 56 enforcement against ten hemp beverage companies, ruling the law conflicts with the federal hemp definition. The state has moved for a stay. Between the county orders and the federal injunction, relief remains plaintiff-specific; the ban stands for everyone else.

Federal level. Two active legislative efforts could modify Section 781 before it takes effect. A third passed the Senate 90 to 6 on August 8: the continuing resolution confining Section 781 to non-natural cannabinoids until December 11, covered in the update log above and still waiting on the House. The Cannabinoid Safety and Regulation Act (S. 3474), introduced in December 2025 by Senators Wyden and Merkley, would replace the November 12 ban with a regulated system: 5mg THC per serving, 50mg per container, 21-and-over, mandatory testing, packaging standards. The bill has not moved out of committee.

Separately, the House passed Chairman Glenn Thompson's Farm Bill (H.R. 7567) 224 to 200 on April 30 with no relief for consumable hemp. A delay amendment from Representative Jim Baird was ruled not germane before the floor vote. The bill codifies the total-THC testing standard for cultivation and now sits in the Senate, where hemp advocates hope for an amendment and have no committed vehicle for one. The FDA's cannabinoid lists, due within 90 days of enactment, remain unpublished eight months in, so producers still lack the official list of which cannabinoids count toward the THC-class total and the final definition of a container.

President Trump issued an executive order in December 2025 directing executive departments and agencies to develop regulations for hemp-derived THC products and expand research into them. Hemp advocates see it as promising. It does not repeal Section 781, which only Congress can do, but it does signal a policy preference for regulation over outright prohibition. In April, Trump publicly called on Congress to amend the law to preserve access to full-spectrum CBD products, a statement that has so far moved no legislation.

Most plausible outcome: the federal deadline takes effect on schedule. State-level litigation carves out exceptions in Texas, Ohio, and possibly other states for specific product categories or specific plaintiffs. Federal enforcement is uneven, concentrated on interstate distributors and large online retailers, and largely absent at the level of individual smoke shops and convenience stores. Payment processing, insurance, and commercial leasing withdraw support for hemp-derived products regardless of enforcement pattern, which drives the commercial shutdown faster than federal action alone would.

When does the hemp ban start affecting store shelves?

The legal deadline is November 12, 2026, but the practical contraction starts months earlier. Processors stop buying biomass in July or August because finished product cycles run 60 to 90 days. Retail selection thins by September, gets cut in half by October, and bottoms out in early November as the largest chains burn through reserves.

For the full schedule of every milestone between now and November, see our hemp ban timeline.

For hemp operators, the real sales deadline comes ahead of November 12 because processors stop buying raw biomass when they can't sell the finished product in time to liquidate. Working back from November 12 through a typical 60-90 day manufacturing and distribution cycle, the last viable purchase orders for conversion-grade CBD biomass go out in July or August 2026. Cultivators who planted in spring 2026 expecting normal buyer demand will find the buyer pool thinning dramatically by late summer.

For retailers, shelf availability of hemp-derived intoxicating products starts contracting in September as distributors prioritize their existing customer relationships and stop accepting new orders. By October, expect product selection at most independent smoke shops and vape stores to be cut roughly in half. By early November, only the largest chains with the deepest inventory reserves will still be carrying full assortments.

For consumers who want to stock up before the ban takes effect, the window is narrower than the November 12 date suggests. The effective shopping deadline is August for full product selection, October for limited selection.

For hemp operators considering cross-border inventory movements, the federal illegality kicks in at the November 12 stroke. After that date, exporting plant material that no longer qualifies as federally lawful hemp becomes unlawful, even for crops cultivated prior to the deadline. Customs export procedures, carrier policies, and foreign import certification requirements all close simultaneously. Inventory held on November 13 that doesn't meet the new thresholds becomes effectively immovable and subject to destruction.

State-by-state impact

The law is federal, but the consumer experience is state-specific. How hard the November 12 transition hits you depends entirely on whether you have access to a state-licensed cannabis program.

Adult-use legal states (California, Colorado, Michigan, Massachusetts, Illinois, New York, New Jersey, Nevada, Oregon, Washington, Maryland, Arizona, Missouri, Minnesota, and others): The ban is an inconvenience, not a crisis. Dispensary channels continue operating unchanged. Expect dispensary traffic to increase and prices to hold or tick up modestly as displaced hemp-derived consumers migrate in. The product quality difference matters: dispensary cannabis is lab-tested, dose-accurate, and tracked seed-to-sale. The hemp-derived products many consumers were buying online were not any of those things.

See our dispensary directories for state-specific guides: California, Michigan, Illinois, Colorado, Massachusetts, New York, New Jersey, Nevada, Oregon, Washington, Maryland, Arizona, Missouri, Minnesota.

Medical-only states (Florida, Pennsylvania, Ohio, Kentucky, North Carolina, Texas medical program, Georgia, and several others): Access narrows but doesn't disappear. If you qualify for a medical card, the program becomes your primary channel after November 12. Qualifying conditions vary by state but have generally expanded over the past three years. For consumers who were using hemp-derived products precisely because they couldn't access a dispensary, the card application is worth pursuing.

No-access states (Idaho, Wyoming, South Dakota, Nebraska, Kansas, and a handful of others): These are the hardest-hit jurisdictions. Low-dose CBD products that meet the 0.4mg cap will remain available, but anything with meaningful psychoactive effect becomes legally unavailable without traveling to a recreational state. Interstate travel to purchase personal-use quantities in a legal state is a federal offense under the Controlled Substances Act, though it's rarely prosecuted. State-level legalization pressure is likely to intensify in these jurisdictions through 2027-2028 as the commercial vacuum created by the ban pushes demand toward either state reform or gray-market supply.

Active state-level litigation states (Texas, Ohio): The short-term picture keeps moving. In Texas, the state rules are back in effect after the June 8 appeals court order, with the July 27 merits trial vacated as the case moved up on appeal. In Ohio, SB 56 stands, with narrow court-ordered carve-outs for specific plaintiffs as the only active relief. The federal November 12 deadline applies in both states regardless of how the state cases resolve. Winning at the state level is a partial victory at best.

What should I do now if I buy hemp-derived edibles?

The path depends on state access. In adult-use states, transition to a dispensary before November 12 and learn the menu. In medical-only states, apply for a card now since processing takes weeks. In no-access states, low-dose CBD under 0.4mg per container stays legal but THC-bearing products become unavailable through legal channels.

Four reader types, four action paths.

If you're a hemp-derived THC consumer in a state with dispensary access, your transition is to the local dispensary starting at some point between now and November 12. The product will be more expensive per milligram, better on every quality dimension, and legal. You will need ID. If you're in a medical-only state, you'll need a card. Use the months before November to visit a dispensary, understand the product menu, identify brands that work for you, and build a supply relationship. Brands with strong state-licensed footprints that we review regularly include Kiva, Wyld, Wana, Papa & Barkley, 1906, Camino, and Smokiez.

If you're a hemp-derived consumer in a state with no dispensary access, start by researching whether your state has any medical program at all (even a limited one) and whether you qualify. Qualifying conditions have expanded significantly over the past three years in states like Texas, Georgia, Kentucky, and North Carolina. If no medical pathway exists and interstate travel isn't feasible, low-dose CBD products that meet the new 0.4mg cap remain available and legal. Products with meaningful THC content become effectively unavailable through legal channels after November 12.

If you're a CBD consumer (non-intoxicating use for sleep, pain, topical applications), most of your purchasing patterns are unaffected. Check the labels on products you currently buy against the 0.4mg per container threshold. Isolate-based products generally pass. Full-spectrum products generally fail. Switching to compliant alternatives before November 12 ensures uninterrupted access. Brands like Charlotte's Web and the isolate lines from larger operators are positioned to continue supplying the CBD-only market legally.

If you're a hemp industry operator, the action path depends on your product mix, your state, and your capital position. Reformulate intoxicating products to compliant CBD isolate formulations where possible. Pursue state cannabis licenses where your state program is accepting applications (this is a multi-year pathway, not a November fix). Liquidate non-compliant inventory on the fastest realistic timeline, recognizing that the effective sales deadline is August-September, not November. Consult counsel on bankruptcy eligibility and federal controlled-substance exposure.

What this means for the state-licensed cannabis edibles market

EdibleRank covers state-licensed cannabis edibles almost exclusively. The November 12 ban is net positive for the category we cover.

Demand migration from hemp-derived channels to dispensary channels is the primary shift. How much demand migrates depends on state access. In states with mature adult-use markets (California, Michigan, Illinois, Massachusetts), the migration is substantial and dispensary producers will ramp up capacity to meet it. In states with weaker medical programs or no access at all, migration is partial or nonexistent.

Price effects are modest and depend on supply capacity. State-licensed producers have existing manufacturing infrastructure and regulatory capacity to scale, but new edibles capacity takes months to bring online. Expect dispensary edibles prices to hold steady or tick up 5-15% through the first half of 2027 as supply catches up to new demand.

Brand consolidation accelerates. Brands that have been operating disciplined state-licensed businesses (Kiva, Wyld, Wana, Papa & Barkley, 1906, Smokiez, Mary's Medicinals, Camino, and others we review regularly) are positioned to gain share. Brands that were riding the hemp-derived channel as a growth vector are positioned to lose. Surviving the ban is one bar. Qualifying as a medical product is a higher one, and the rubric for that is laid out in what a medically endorsed edible would actually look like. For our reader taxonomy of which specific brands survive and which don't, see which cannabis brands survive the 2026 hemp ban.

Last word

The 2026 hemp ban is the largest single disruption to cannabis retail since 2018. For consumers who've been buying hemp-derived intoxicating products online or at smoke shops, it's the end of a product category. For the state-licensed cannabis industry, it's a consolidation event. We argue the same point at category scale in The Future Is Edible: the ban compresses about three years of consolidation into about six months, and the format that absorbs the displaced demand is overwhelmingly oral, not combusted. For the hemp industry itself, it's existential. The underlying policy direction (federal government increasingly inclined to treat intoxicating cannabinoids as a state-regulated category instead of a federally-unregulated one) is unlikely to reverse regardless of how Section 781 is modified or litigated.

This page gets updated whenever the situation moves. Bookmark it. Check back when news breaks. The update log at the top will tell you what's new.